REGULATORYRFK Jr.: 14 peptides returning to Category 1 — FDA advisory committee July 2026TRENDINGHexarelin: ↑↑ Surging ��� Trends score 100 as of May 2026UPDATESemaglutide and tirzepatide compounding ended — shortage resolved Feb/May 2025REGULATORYBPC-157, TB-500, thymosin alpha-1, CJC-1295, ipamorelin: expected Category 1 reclassification pendingEVENTpep-talk con ��� First US Peptide Convention · August 2026 · Anaheim CAFDAFDA advisory committee meetings scheduled: late July 2026REGULATORYRFK Jr.: 14 peptides returning to Category 1 — FDA advisory committee July 2026TRENDINGHexarelin: ↑↑ Surging ��� Trends score 100 as of May 2026UPDATESemaglutide and tirzepatide compounding ended — shortage resolved Feb/May 2025REGULATORYBPC-157, TB-500, thymosin alpha-1, CJC-1295, ipamorelin: expected Category 1 reclassification pendingEVENTpep-talk con ��� First US Peptide Convention · August 2026 · Anaheim CAFDAFDA advisory committee meetings scheduled: late July 2026

For research purposes only. Full disclaimer →

Research/Paper
Back to Research Library
PubMedRandomized Controlled Trial

Acute salivary antimicrobial peptide secretion response to different exercise intensities and durations.

Ito Reita, Uchino Takamasa, Uchida Masataka, Fujie Shumpei, Iemitsu Keiko, Kojima Chihiro, Nakamura Mariko, Shimizu Kazuhiro, Tanimura Yuko, Shinohara Yasushi
American journal of physiology. Regulatory, integrative and comparative physiology2024DOI: 10.1152/ajpregu.00132.2024

Citations

0

Subjects

Non-Human

Study Context

Randomized controlled trials are the gold standard for evaluating treatment efficacy. The randomized design minimizes bias, making findings more reliable for clinical decision-making.

Citation

Ito Reita, Uchino Takamasa, Uchida Masataka et al.. (2024). Acute salivary antimicrobial peptide secretion response to different exercise intensities and durations.. American journal of physiology. Regulatory, integrative and comparative physiology. https://doi.org/10.1152/ajpregu.00132.2024

View full text on PubMed

This content is derived from peer-reviewed research for educational purposes only. It does not constitute medical advice. Always consult a qualified healthcare provider before using any peptide-based therapy.